HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
LSR
lipolysis stimulated lipoprotein receptor
Chromosome 19 · 19q13.12
NCBI Gene: 51599Ensembl: ENSG00000105699.17HGNC: HGNC:29572UniProt: A0A8Z5AA41
99PubMed Papers
20Diseases
0Drugs
2Pathogenic Variants
FUNCTIONAL ROLE
Receptor
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
extracellular exosomeplasma membranetight junctioncell junctionneurodegenerative diseaseprogressive familial intrahepatic cholestasisprogressive familial intrahepatic cholestasis type 1Short stature
✦AI Summary

LSR (lipolysis stimulated lipoprotein receptor), also known as angulin-1, is a tricellular tight junction protein that plays dual roles in epithelial barrier maintenance and cancer progression. LSR localizes to tricellular tight junction contacts where it colocalizes with tricellulin to maintain epithelial barrier function 1. In endometrial cancer, LSR expression decreases with cancer grade progression, and its suppression promotes malignancy through activation of Yes-associated protein (YAP) signaling, leading to increased cell migration and invasion 1. Similarly, in lung adenocarcinoma, downregulation of LSR induces malignant behavior through EGF-dependent claudin-2 upregulation and TGF-β-dependent metabolic changes 2. LSR expression is altered in a menstrual cycle-dependent manner in normal endometrial tissue, and these alterations are disrupted during endometrial cancer progression 3. The protein functions by recruiting other tight junction molecules like tricellulin to tricellular contacts, and its loss leads to epithelial barrier dysfunction associated with cancer progression and metastasis 3. LSR represents a critical regulator of epithelial integrity whose dysfunction contributes to cancer malignancy through multiple signaling pathways.

Sources cited
1
LSR colocalizes with tricellulin at tricellular contacts and its suppression promotes malignancy via YAP signaling in endometrial cancer
PMID: 32266459
2
Downregulation of LSR induces malignancy through EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in lung adenocarcinoma
PMID: 36961882
3
LSR/angulin-1 localizes at tricellular contacts for epithelial barrier maintenance and is altered in cancer progression
PMID: 31330820
⚠Limited data available — This gene has 3 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.34Weak
progressive familial intrahepatic cholestasisOpen Targets
0.27Weak
progressive familial intrahepatic cholestasis type 1Open Targets
0.27Weak
Intellectual disabilityOpen Targets
0.18Weak
Short statureOpen Targets
0.18Weak
lysosomal storage diseaseOpen Targets
0.11Weak
triple-negative breast cancerOpen Targets
0.07Suggestive
endometrial cancerOpen Targets
0.06Suggestive
lung adenocarcinomaOpen Targets
0.04Suggestive
neoplasmOpen Targets
0.04Suggestive
gliomaOpen Targets
0.04Suggestive
endometriosisOpen Targets
0.04Suggestive
gastric cancerOpen Targets
0.03Suggestive
lung cancerOpen Targets
0.03Suggestive
hepatocellular carcinomaOpen Targets
0.03Suggestive
breast cancerOpen Targets
0.03Suggestive
viral diseaseOpen Targets
0.03Suggestive
infectionOpen Targets
0.02Suggestive
urinary bladder carcinomaOpen Targets
0.02Suggestive
malignant gliomaOpen Targets
0.02Suggestive
Pathogenic Variants2
NM_205834.4(LSR):c.779-2A>GLikely pathogenic
Progressive familial intrahepatic cholestasis
★☆☆☆2025
NM_205834.4(LSR):c.353G>C (p.Cys118Ser)Likely pathogenic
Progressive familial intrahepatic cholestasis type 1
★☆☆☆→ Residue 118
View on ClinVar ↗
Related Genes
APOEProtein interaction100%MARVELD2Protein interaction95%HRNRShared pathway25%PRRC1Shared pathway25%GFERShared pathway25%DBPShared pathway25%
Tissue Expression6 tissues
Liver
100%
Lung
15%
Brain
10%
Ovary
5%
Bone Marrow
5%
Heart
4%
Gene Interaction Network
Click a node to explore
LSRAPOEMARVELD2HRNRPRRC1GFERDBP
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q86X29
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.96LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.74 [0.58–0.96]
RankingsWhere LSR stands among ~20K protein-coding genes
  • #4,843of 20,598
    Most Researched99 · top quartile
  • #4,323of 5,498
    Most Pathogenic Variants2
  • #9,047of 17,882
    Most Constrained (LOEUF)0.96
Genes detectedLSR
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute pain.
PMID: 40010720
Drug Discov Ther · 2025
1.00
2
Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance.
PMID: 33751445
J Neuroimmune Pharmacol · 2021
0.90
3
Living Systematic Reviews.
PMID: 34550587
Methods Mol Biol · 2022
0.80
4
ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer.
PMID: 32266459
Histochem Cell Biol · 2020
0.70
5
Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells.
PMID: 36961882
Oncotarget · 2023
0.60